Published in Graefes Arch Clin Exp Ophthalmol on April 25, 2014
Real-life experience after intravitreal ocriplasmin for vitreomacular traction and macular hole: a spectral-domain optical coherence tomography prospective study. Graefes Arch Clin Exp Ophthalmol (2015) 0.97
A retrospective cohort study in patients with tractional diseases of the vitreomacular interface (ReCoVit). Graefes Arch Clin Exp Ophthalmol (2016) 0.84
The design and validation of an optical coherence tomography-based classification system for focal vitreomacular traction. Eye (Lond) (2016) 0.78
Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med (2012) 8.83
High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology (2006) 3.51
The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology (2013) 2.35
Vitreomacular adhesion and neovascular age-related macular degeneration. Surv Ophthalmol (2012) 2.27
Posterior vitreous detachment: evolution and complications of its early stages. Am J Ophthalmol (2010) 2.18
Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology (2010) 2.02
Course of vitreomacular traction syndrome. Am J Ophthalmol (1995) 1.80
Vitreomacular traction syndrome: a comparison of treatment with intravitreal plasmin enzyme vs spontaneous vitreous separation without treatment. Eye (Lond) (2012) 1.60
Spontaneous separation of epiretinal membrane in young subjects: personal observations and review of the literature. Graefes Arch Clin Exp Ophthalmol (2004) 1.59
Anatomy and pathology of the vitreo-retinal interface. Eye (Lond) (1992) 1.45
Optical coherence tomography use in evaluation of the vitreoretinal interface: a review. Surv Ophthalmol (2007) 1.41
Surgical results in the vitreomacular traction syndrome. Ophthalmology (1994) 1.37
Long-term evaluation of vitreomacular traction disorder in spectral-domain optical coherence tomography. Retina (2011) 1.26
Vitrectomy for macular traction caused by incomplete vitreous separation. Arch Ophthalmol (1988) 1.22
Tractional cystoid macular edema: a subtle variant of the vitreomacular traction syndrome. Am J Ophthalmol (2005) 1.09
Residual vitreous cortex after surgical posterior vitreous separation visualized by intravitreous triamcinolone acetonide. Ophthalmology (2004) 1.06
Optic disc, foveal, and extrafoveal damage due to surgical separation of the vitreous. Arch Ophthalmol (2001) 1.05
High-resolution optical coherence tomography after surgery for vitreomacular traction: a 2-year follow-up. Ophthalmology (2010) 1.05
Intravitreal injection of expansile perfluoropropane (c(3)f(8)) for the treatment of vitreomacular traction. Am J Ophthalmol (2012) 1.02
Emerging nonsurgical methods for the treatment of vitreomacular adhesion: a review. Clin Ophthalmol (2011) 1.00
Vitrectomy for vitreomacular traction syndrome with macular detachment. Retina (1995) 0.97
Vitrectomy for macular pucker and vitreomacular traction syndrome. Doc Ophthalmol (1999) 0.88
Pharmacologic vitreolysis--premise and promise of the first decade. Retina (2009) 0.84
Spontaneous resolution of vitreomacular traction demonstrated by spectral-domain optical coherence tomography. Am J Ophthalmol (2014) 0.83
Posterior vitreous detachment: evolution and role in macular disease. Retina (2012) 0.81
Vitreomacular traction syndrome. Retina (2012) 0.81
The natural history of tractional cystoid macular edema. Retina (2012) 0.80
Volumetric assessment of the space between the posterior hyaloid and internal limiting membrane using SD-OCT. Br J Ophthalmol (2013) 0.77
Spontaneous resolution of vitreomacular traction: a case series. Clin Exp Optom (2013) 0.75
Optical coherence tomographic findings of vitreomacular traction syndrome with macular hole retinal detachment. Clin Experiment Ophthalmol (2008) 0.75
Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology (2010) 7.30
The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology (2011) 6.33
Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology (2011) 4.61
Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care (2010) 3.29
Retreatment with Ozurdex for macular edema secondary to retinal vein occlusion. Eur J Ophthalmol (2013) 2.44
Intravitreal dexamethasone implant (Ozurdex) for macular edema secondary to retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol (2012) 2.28
Impending corneal perforation after collagen cross-linking for herpetic keratitis. J Cataract Refract Surg (2013) 2.13
Repeatability and reproducibility of fast macular thickness mapping with stratus optical coherence tomography. Arch Ophthalmol (2005) 2.12
Impact of intravitreal dexamethasone implant (Ozurdex) on macular morphology and function. Retina (2014) 2.11
Intravitreal ranibizumab for naive extrafoveal choroidal neovascularization secondary to age-related macular degeneration. Retina (2014) 2.04
Changes in macular function after ozurdex for retinal vein occlusion. Optom Vis Sci (2014) 2.02
Use of capsular tension ring in phacoemulsification. Indications and technique. Indian J Ophthalmol (2002) 1.50
Idiopathic macular hole surgery with low-concentration infracyanine green-assisted peeling of the internal limiting membrane. Am J Ophthalmol (2006) 1.41
Correspondence. Retina (2017) 1.40
Tear osmolarity in ocular graft-versus-host disease. Cornea (2014) 1.40
SD OCT features of dry arcuate longstanding retinal folds. Eur J Ophthalmol (2011) 1.38
Hyperreflective pyramidal structures on optical coherence tomography in geographic atrophy areas. Retina (2014) 1.31
Anxiety and depression prevalence rates in age-related macular degeneration. Invest Ophthalmol Vis Sci (2007) 1.25
Repeated intravitreal dexamethasone implant (Ozurdex®) for retinal vein occlusion. Ophthalmologica (2012) 1.23
Retinal nerve fiber layer thickness reproducibility using seven different OCT instruments. Invest Ophthalmol Vis Sci (2012) 1.23
Guidance for the treatment of neovascular age-related macular degeneration. Acta Ophthalmol Scand (2007) 1.17
Safety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programme. Br J Ophthalmol (2013) 1.16
Management of retinal vein occlusion--consensus document. Ophthalmologica (2011) 1.14
Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence. Graefes Arch Clin Exp Ophthalmol (2012) 1.14
Intravitreal dexamethasone implant in patients with persistent diabetic macular edema. Ophthalmologica (2012) 1.13
Spontaneous resolution of a shallow detachment of the macula in a highly myopic eye. Am J Ophthalmol (2003) 1.11
Outcome of choroidal neovascularization in angioid streaks after photodynamic therapy. Retina (2004) 1.10
Enhanced depth imaging optical coherence tomography in type 2 diabetes. Invest Ophthalmol Vis Sci (2012) 1.10
Optical coherence tomography versus stereoscopic fundus photography or biomicroscopy for diagnosing diabetic macular edema: a systematic review. Invest Ophthalmol Vis Sci (2007) 1.09
Correspondence. Retina (2013) 1.08
Correspondence to: Use of spectral-domain optical coherence tomography to differentiate acquired retinoschisis from retinal detachment in difficult cases. Retina (2013) 1.08
Macular hole following intravitreal ranibizumab injection for choroidal neovascular membrane caused by age-related macular degeneration. Acta Ophthalmol (2009) 1.06
Intravitreal ranibizumab for choroidal neovascularization complicating pathologic myopia. Retina (2010) 1.05
Correspondence. Retina (2015) 1.05
Analysis of progression of reticular pseudodrusen by spectral domain-optical coherence tomography. Invest Ophthalmol Vis Sci (2012) 1.05
Branch retinal vein occlusion: classification and treatment. Ophthalmologica (2009) 1.04
Onset and duration of visual acuity improvement after dexamethasone intravitreal implant in eyes with macular edema due to retinal vein occlusion. Retina (2014) 1.04
Hyperreflective dots: a new spectral-domain optical coherence tomography entity for follow-up and prognosis in exudative age-related macular degeneration. Ophthalmologica (2012) 1.03
TYPE 2 NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION IMAGED BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. Retina (2015) 1.01
Type 3 neovascularization: evolution, association with pigment epithelial detachment, and treatment response as revealed by spectral domain optical coherence tomography. Retina (2015) 1.01
Diurnal variation in clinically significant diabetic macular edema measured by the Stratus OCT. Retina (2006) 0.99
Juxtafoveal choroidal neovascularization associated with retinitis pigmentosa treated with intravitreal bevacizumab. J Ocul Pharmacol Ther (2011) 0.99
Fundus autofluorescence. Ophthalmology (2007) 0.98
Intravitreal ranibizumab versus bevacizumab for treatment of myopic choroidal neovascularization. Retina (2012) 0.98
Multimodal imaging of dry age-related macular degeneration. Acta Ophthalmol (2012) 0.96
Repeated intravitreal dexamethasone implant (Ozurdex) for diabetic macular edema. Retina (2015) 0.95
Comparison of macular choroidal thickness in adult onset foveomacular vitelliform dystrophy and age-related macular degeneration. Invest Ophthalmol Vis Sci (2014) 0.95
Intravitreal bevacizumab versus ranibizumab for the treatment of retinal angiomatous proliferation. Acta Ophthalmol (2011) 0.95
Laser photocoagulation, photodynamic therapy, and intravitreal bevacizumab for the treatment of juxtafoveal choroidal neovascularization secondary to pathologic myopia. Arch Ophthalmol (2010) 0.95
Bevacizumab vs photodynamic therapy for choroidal neovascularization in multifocal choroiditis. Arch Ophthalmol (2010) 0.94
INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN ANGIOID STREAKS: Four-Year Follow-up. Retina (2016) 0.94
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FEATURES OF SUBRETINAL FIBROSIS IN AGE-RELATED MACULAR DEGENERATION. Retina (2015) 0.93
Genotype-phenotype correlations for exudative age-related macular degeneration associated with homozygous HTRA1 and CFH genotypes. Invest Ophthalmol Vis Sci (2008) 0.93
Experience with the Pascal® photocoagulator: an analysis of over 1,200 laser procedures with regard to parameter refinement. Indian J Ophthalmol (2011) 0.93
Patient-reported visual function outcomes improve after ranibizumab treatment in patients with vision impairment due to diabetic macular edema: randomized clinical trial. JAMA Ophthalmol (2013) 0.93
Oral docosahexaenoic acid in the prevention of exudative age-related macular degeneration: the Nutritional AMD Treatment 2 study. Ophthalmology (2013) 0.92
Analysis of retinal flecks in fundus flavimaculatus using high-definition spectral-domain optical coherence tomography. Am J Ophthalmol (2010) 0.92
The role of angiogenesis in the development of proliferative diabetic retinopathy: impact of intravitreal anti-VEGF treatment. Exp Diabetes Res (2012) 0.91
Quality of life in patients with uveitis on chronic systemic immunosuppressive treatment. Ocul Immunol Inflamm (2010) 0.91
Leukaemic infiltration of the retina at onset of Philadelphia-positive acute lymphoblastic leukaemia revealed by stratus optical coherence tomography. Br J Haematol (2006) 0.91
Accidental injection of dexamethasone intravitreal implant in the crystalline lens. Acta Ophthalmol (2013) 0.91
Preferential hyperacuity perimeter as a functional tool for monitoring exudative age-related macular degeneration in patients treated by intravitreal ranibizumab. Invest Ophthalmol Vis Sci (2011) 0.91
Stereotactic radiotherapy for neovascular age-related macular degeneration: 52-week safety and efficacy results of the INTREPID study. Ophthalmology (2013) 0.91
Review on the worldwide epidemiology of uveitis. Eur J Ophthalmol (2013) 0.90
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN EARLY TYPE 3 NEOVASCULARIZATION. Retina (2015) 0.90
Intravitreal Ranibizumab for myopic choroidal neovascularization after pars plana vitrectomy and silicone oil tamponade. Eur J Ophthalmol (2013) 0.90
Retinal venous occlusions: diagnosis and choice of treatments. Ophthalmic Res (2013) 0.90
Sequential anterior ischemic optic neuropathy and central retinal artery and vein occlusion after ranibizumab for diabetic macular edema. Eur J Ophthalmol (2010) 0.90
Microperimetric correlations of autofluorescence and optical coherence tomography imaging in dry age-related macular degeneration. Am J Ophthalmol (2012) 0.90
Intravitreal ranibizumab for choroidal neovascularization with large submacular hemorrhage in age-related macular degeneration. Retina (2014) 0.89
Intravitreal ranibizumab injection for nonarteritic ischemic optic neuropathy. J Ocul Pharmacol Ther (2010) 0.89
Genetic factors associated with age-related macular degeneration. Ophthalmologica (2011) 0.89
Retinal vein occlusion: current treatment. Ophthalmologica (2010) 0.88
Outcome of 110 basal cell carcinomas of the eyelid treated with frozen section-controlled excision: mean follow-up over 5 years. Eur J Ophthalmol (2013) 0.88
Intravitreal bevacizumab for extrafoveal choroidal neovascularization after ocular trauma. J Ocul Pharmacol Ther (2012) 0.88
Intravitreal bevacizumab for a subfoveal myopic choroidal neovascularization in the first trimester of pregnancy. J Ocul Pharmacol Ther (2012) 0.87
En face enhanced depth imaging optical coherence tomography of fibrovascular pigment epithelium detachment. Invest Ophthalmol Vis Sci (2012) 0.87
Angiographic evidence of retinal artery transient occlusion in paracentral acute middle maculopathy. Retina (2014) 0.87
Update of intravitreal steroids for the treatment of diabetic macular edema. Ophthalmic Res (2014) 0.86
Clinical and laboratory factors associated with the severity of proliferative sickle cell retinopathy in patients with sickle cell hemoglobin C (SC) and homozygous sickle cell (SS) disease. Medicine (Baltimore) (2011) 0.86
Antivascular endothelial growth factors for inflammatory chorioretinal disorders. Dev Ophthalmol (2010) 0.86
Near-infrared fundus autofluorescence in multiple evanescent white-dot syndrome. Eur J Ophthalmol (2014) 0.86
Unilateral vitelliform phenotype in autosomal recessive bestrophinopathy. Ophthalmic Res (2012) 0.86
The role of optical coherence tomography (OCT) in the diagnosis and management of retinal angiomatous proliferation (RAP) in patients with age-related macular degeneration. Ann Acad Med Singapore (2006) 0.85
Rituximab for uveitis. Ophthalmology (2011) 0.84
Retinal involvement in nephrotic syndrome secondary to minimal change disease. Eur J Ophthalmol (2012) 0.84
Bilateral choroidal excavation in best vitelliform macular dystrophy. Ophthalmic Surg Lasers Imaging Retina (2014) 0.84
Intravitreal bevacizumab for subfoveal choroidal neovascularization associated with pattern dystrophy. Invest Ophthalmol Vis Sci (2010) 0.84